Vixex Archives - Spinal Surgery News

26 May 2020

Initial Vivex VIA Disc study shows promising potential of injectable treatment option

A non-surgical, injectable treatment option from Vivex for sufferers of chronic lower back pain brought about by degenerative disc disease...

and receive all of the latest news via our weekly newsletter

"*" indicates required fields

About Us

Spinal Surgery News online features news, opinions, events, reviews, product information and a wide range of peer-reviewed scientific material of interest to specialist spinal professionals.

The journal has several eminent editorial contributors guiding its content; and we also work closely with companies in the industry to ensure it remains useful and relevant.

Vixex

Initial Vivex VIA Disc study shows promising potential of injectable treatment option

Tethered Spinal Cord Syndrome (TSCS): Pathophysiology and clinical presentation with a focus on anaesthetic management

Physicoll collagen supplement supports holistic post-surgery recovery

Avicenna.AI lands FDA clearance for AI tool that detects cervical spine fracture

Scoliosis Research Society announces recipients for the Lifetime Achievement Award

24th-27th April 2025, NSpine Combined Cadaveric & Live Tissue Training; France

13-17 January 2025, NSpine Winter Masterclass; Switzerland

About Us

Vixex

Initial Vivex VIA Disc study shows promising potential of injectable treatment option

and receive all of the latest news via our weekly newsletter

Tethered Spinal Cord Syndrome (TSCS): Pathophysiology and clinical presentation with a focus on anaesthetic management

Physicoll collagen supplement supports holistic post-surgery recovery

Avicenna.AI lands FDA clearance for AI tool that detects cervical spine fracture

Scoliosis Research Society announces recipients for the Lifetime Achievement Award

24th-27th April 2025, NSpine Combined Cadaveric & Live Tissue Training; France

13-17 January 2025, NSpine Winter Masterclass; Switzerland

About Us

Subscribe

and receive all of the latest news via our weekly newsletter